Karl Stark, one of the featured writers for the Philadelphia Inquirer and someone who has closely followed the drug industry over the last few years, joins Scott Drake of The Legal Broadcast Network to discuss the recent Federal Appeals court ruling that seems to indicate that preemption is going to be the law of the land regarding FDA warning labels and liability.

As you know, LBN has been following this story over the past few months, and in this podcast Karl Stark goes into the 2-1 ruling from a Federal Appeals court panel that sided with the drug industry on the sufficiency of warnings on drug labels.

You can listen to the entire podcast by clicking here.

Or you can go to Speaking of Justice to download the full podcast or cut and paste it to your site.

Preemption is going to be addressed by the full Supreme Court in the Wyeth vs Levine case that is in the current docket, but this appeals court ruling adds further momentum to the argument that the FDA is going to be providing cover to drug companies in state courts regarding their potentially defective or dangerous products. This podcast gives you a quick back ground of what has gone on so far, gives you the framework of what the Wyeth v Levine case is going to be about and the potential impact to trial lawyers and injured parties in the year ahead.  

You may also read the entire article from Karl Stark by clicking here.